← FDA Drug Approvals (Drugs@FDA)
MOMETASONE FUROATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-06-14
Drug application
- FDA Application #
ANDA217460- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MOMETASONE FUROATE
- Generic name
- Mometasone Furoate
- Active ingredients
- MOMETASONE FUROATE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Discontinued
- Sponsor
- AMNEAL
- First approval
- 2023-06-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown